Skip to main content

Table 3 Incidence and risk ratio of adverse events between the two treatment groups

From: Efficacy of glucosamine plus diacerein versus monotherapy of glucosamine: a double-blind, parallel randomized clinical trial

Outcomes at 6-month follow-up Treatment RR 95 % CI P value
Glucosamine plus diacerein Glucosamine plus placebo
Diarrhea 0.84 (0.05–0.14) 0.81 (0.05–0.14) 1.03 0.56–1.89 0.932
Dyspepsia 0.03 (0.02–0.06) 0.03 (0.02–0.07) 0.91 0.43–1.92 0.805
  1. RR Risk ratio